3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
8
Prostatic Neoplasms
6
Hematopoietic and Lymphatic System Neoplasm
6
Hematologic Neoplasms
5
Breast Neoplasms
5
Anatomic Stage I Breast Cancer AJCC v8
5
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Neoplasms
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Urinary Bladder Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
COVID-19
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tonsillar Neoplasms
1
Interventions
Radiosurgery
31
Magnetic Resonance Spectroscopy
16
Temozolomide
12
pembrolizumab
11
Nivolumab
10
Specimen Handling
8
Ipilimumab
8
Bevacizumab
8
Radiotherapy
7
Mental Status and Dementia Tests
7
Memantine
7
abemaciclib
5
Blood Specimen Collection
5
Biopsy
4
trastuzumab deruxtecan
3
entrectinib
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Dexamethasone
3
Cyclophosphamide
3
trametinib
2
pertuzumab
2
osimertinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Practice Guidelines as Topic
×
90 days
×
Clear all
No trials found.